26.4 C
Bathinda
Tuesday, April 7, 2026
HomeBusinessMerck Buying Drug Targeting B-Cell Diseases for Up to $1.3 Billion

Merck Buying Drug Targeting B-Cell Diseases for Up to $1.3 Billion

Merck Buying Drug Targeting B-Cell Diseases for Up to .3 Billion

Merck has struck a deal worth up to $1.3 billion to buy an investigational drug targeting B-cell associated diseases.



Source link

Content Protection by DMCA.com
RELATED ARTICLES

Leave a reply

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments